Skip to main content
Erschienen in: Virology Journal 1/2020

Open Access 01.12.2020 | COVID-19 | Research

The chest CT features of coronavirus disease 2019 (COVID-19) in China: a meta-analysis of 19 retrospective studies

verfasst von: Haitao Yang, Yuzhu Lan, Xiujuan Yao, Sheng Lin, Baosong Xie

Erschienen in: Virology Journal | Ausgabe 1/2020

Abstract

Objective

Aimed to summarize the characteristics of chest CT imaging in Chinese hospitalized patients with Coronavirus Disease 2019 (COVID-19) to provide reliable evidence for further guiding clinical routine.

Methods

PubMed, Embase and Web of Science databases were searched to identify relevant articles involving the features of chest CT imaging in Chinese patients with COVID-19. All data were analyzed utilizing R i386 4.0.0 software. Random-effects models were employed to calculate pooled mean differences.

Results

19 retrospective studies (1332 cases) were included. The results demonstrated that the combined proportion of ground-glass opacities (GGO) was 0.79 (95% CI 0.68, 0.89), consolidation was 0.34 (95% CI 0.23, 0.47); mixed GGO and consolidation was 0.46 (95% CI 0.37; 0.56); air bronchogram sign was 0.41 (95% CI 0.26; 0.55); crazy paving pattern was 0.32 (95% CI 0.17, 0.47); interlobular septal thickening was 0.55 (95% CI 0.42, 0.67); reticulation was 0.30 (95% CI 0.12, 0.48); bronchial wall thickening was 0.24 (95% CI 0.11, 0.40); vascular enlargement was 0.74 (95% CI 0.64, 0.86); subpleural linear opacity was 0.28 (95% CI 0.12, 0.48); intrathoracic lymph node enlargement was 0.03 (95% CI 0.00, 0.07); pleural effusions was 0.03 (95% CI 0.02, 0.06). The distribution in lung: the combined proportion of central was 0.05 (95% CI 0.01, 0.11); peripheral was 0.74 (95% CI 0.62, 0.84); peripheral involving central was 0.38 (95% CI 0.19, 0.75); diffuse was 0.19 (95% CI 0.06, 0.32); unifocal involvement was 0.09 (95% CI 0.05, 0.14); multifocal involvement was 0.57 (95% CI 0.48, 0.68); unilateral was 0.16 (95% CI 0.10, 0.23); bilateral was 0.83 (95% CI 0.78, 0.89); The combined proportion of lobes involved (> 2) was 0.70 (95% CI 0.61, 0.78); lobes involved (≦ 2) was 0.35 (95% CI 0.26, 0.44).

Conclusion

GGO, vascular enlargement, interlobular septal thickening more frequently occurred in patients with COVID-19, which distribution features were peripheral, bilateral, involved lobes > 2. Therefore, based on chest CT features of COVID-19 mentioned, it might be a promising means for identifying COVID-19.
Hinweise
Haitao Yang and Yuzhu Lan have contributed equally to this work

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12985-020-01432-9.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
COVID-19
Coronavirus disease 2019
PHEIC
Public health emergency of international concern
CT
Computer tomography
GGO
Ground-glass opacities
SARS
Severe acute respiratory syndrome
MERS
Middle East respiratory syndrome
ACE
Angiotensin-converting enzyme
ACE2
Angiotensin-converting enzyme 2

Introduction

The Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, a new coronavirus of the Sarbe virus subgenus, a member of the orthocoronavirus subfamily [1]. The outbreak of the COVID-19 has resulted in a global pandemic. Up to August 16, 2020, a total of 21,294,865 confirmed cases have been reported in the world, with another 761,779 confirmed deaths [2]. Considering COVID-19 has caused a big threat to global health, WHO announced the event constituted a Public Health Emergency of International Concern (PHEIC), on December 30, 2019. Interrupting the spread of the pandemic has become an urgent problem. In the prevention and treatment of SARS-CoV-2, the "four early" principles (early detection, early diagnosis, early isolation and early treatment) are particularly important. Patients infected with SARS-CoV-2 may have fever, cough, dyspnea, and muscle pain, which are nonspecific [36]. However, the varieties of clinical manifestations, laboratory tests and imaging tests limit clinical diagnosis and treatment. As we all know, real-time reverse transcription-polymerase chain reaction (rRT-PCR) is the reference standard [6, 7]. However, nucleic acid testing is highly laboratory demanding, the long time for results and the false-negative results are harmful for the control of infectious diseases. Moreover, subclinical cases increase the difficulty of diagnosis. Some studies have shown that COVID-19 may have no clinical manifestations, but can find abnormal signals in chest CT [810]. Imaging can be used to guide diagnosis early in the course of the disease or in asymptomatic patients. Chest CT played an important role in timely detecting lung abnormalities, allowing for early treatment. Previous studies focused on the features of CT imaging of COVID-19, whereas the results varieties of different studies. Therefore, it is urgent to conduct this meta-analysis to comprehensively summarize the characteristics of CT imaging of patients with COVID-19 to further guide clinical and scientific research through evidence-based medicine.

Material and methods

Search strategy

Relevant articles were thoroughly searched from PubMed, Embase and Web of Science databases using the following words: "2019-nCoV", "Coronavirus", "COVID-19", "SARS-CoV-2", "Chest computer tomography (CT) manifestations", "Imaging findings", "China", "Chinese". Articles were dated up to 13 May 2020. The language was restricted to English. The identified articles with the references were also searched for extending the search. All recruited articles were performed by two researchers.

Study selection

All articles meeting the following criteria were identified in this study: (1) all patients with COVID-19 were proved by RT-PCR; (2) all articles investigated the features of chest CT imaging with sufficient data; (3) all patients were Chinese; (4) all articles were published in English. Reviews, letters, case reports, ongoing studies and studies with insufficient data were excluded.

Data extraction

Two researchers extracted the data from eligible articles independently. The following data included clinical characteristics (author, published year, sample size, gender, age-range, fever, cough, myalgia or fatigue, sore throat, dyspnea, diarrhea, nausea, and vomiting, study type, a period of study, in-patients, asymptomatic, CT negative group, time of symptom onset to CT) and the features of chest CT [ground-glass opacities (GGO), consolidation, mixed GGO and consolidation, air bronchogram sign, crazy paving pattern, interlobular septal thickening, reticulation, bronchial wall thickening, vascular enlargement, subpleural linear opacity, intrathoracic lymph node enlargement, pleural effusions, central, peripheral, peripheral involving central, unilateral, bilateral, diffuse, unifocal involvement, multifocal involvement, number of lobes involved (> 2), number of lobes involved (≤ 2)]. The third researcher decided once the extracted data existed discrepancy.

Statistical analysis

All data were analyzed utilizing R software version i386 4.0.0. Eligible data were first transformed by one of the methods [raw, i.e. untransformed, proportions (PRAW), log transformation (PLN), logit transformation (PLOGIT), arcsine transformation (PAS), Freeman–Tukey double arcsine transformation (PFT)] to make them conform to normal distribution. Random-effects models were employed to calculate pooled mean differences due to the existed incorporate heterogeneity.

Quality assessment

The quality evaluation of the article was conducted by two investigators independently according to the Newcastle–Ottawa Scale (NOS). When the results were inconsistent, discussion or decision would be made by the third investigator. 8 items from the three aspects of crowd selection, comparability and exposure, which was evaluated by star rating. The full score is 9 stars, ≥ 6 stars were regarded as high quality article, otherwise, low quality article.

Publication bias

A minimum of 10 studies was needed to assess the potential publication bias, therefore we conducted the Egger test to assess this publication bias.

Results

Literature search and clinical characteristics

Firstly, the above terms were used to comprehensively search from 3 databases and included 21,214 articles. Secondly, 11,988 articles were excluded by checking duplication. Furthermore, 9171 articles were excluded by reading abstract and title; 36 articles were excluded by reading full text (13 articles were case reports; 3 articles included only children or pregnant women; 3 articles were not Chinese). Eventually, 19 articles (1332 cases) [8, 1128] were recruited to perform this meta-analysis to describe the chest CT feature of COVID-19. The process of searching was shown in Fig. 1, and the clinical features of the included studies was described in Tables 1 and 2. Quality evaluation of the included studies were described in Table 2. The exact search string and settings for each database (Additional file 1) and the 36 references of exclusion (Additional file 2) were described on the additional files.
Table 1
The characteristics of included studies
References
Sample size
Gender
Age range
Symptoms
Male
Female
Fever
Cough
Myalgia or fatigue
Sore throat
Dyspnea
Diarrhea
Nausea and vomiting
Sputum
Headache
Zhao et al. [11]
101
56
45
44.4 (17–75)
79
63
17
12
1
3
2
NA
NA
Xu et al. [12]
90
39
51
50 (18–86)
70
57
25
23
NA
5
2
NA
NA
Han et al. [13]
108
38
70
45 (21–90)
94
65
56
14
NA
15
NA
NA
NA
Li and Xia [14]
53
28
23
58 (26–83)
46
1
3
NA
NA
NA
NA
NA
NA
Xiong et al. [15]
42
25
17
49.5 (26–75)
36
27
14
NA
8
10
NA
NA
NA
Cheng et al. [16]
11
8
3
50.36
8
7
3
1
1
NA
NA
3
NA
Xu et al. [17]
50
29
21
13.9 (3–85)
43
20
16
4
4
1
1
NA
5
Yuan et al. [18]
27
12
15
60 (47–69)
21
16
3
NA
11
NA
NA
NA
NA
Chung et al. [19]
21
13
8
51 (29–77)
14
9
6
NA
NA
NA
1
NA
3
Zhang et al. [20]
17
8
9
48.6 (23–74)
12
9
13
1
1
NA
NA
7
4
Pan et al. [21]
63
33
30
44.9
NA
NA
NA
NA
NA
NA
NA
NA
NA
Shi et al. [8]
81
42
39
19.5 (25–81)
59
48
7
NA
34
3
4
15
5
Li et al. [22, 29]
90
44
39
45.5
72
65
15
6
9
7
NA
15
9
Bernheim et al. [23]
121
61
60
45.3 (18–80)
74
58
NA
NA
NA
NA
NA
20
NA
Wu et al. [24]
80
38
42
44
61
58
13
9
7
7
NA
11
8
Guan et al. [25]
53
25
28
42 (1–86)
NA
NA
NA
NA
NA
NA
NA
NA
NA
Bai et al. [26]
219
119
100
44.8 ± 14.5 (4–76)
142
NA
NA
NA
NA
NA
NA
NA
NA
Song et al. [28]
51
25
26
49 ± 16
49
24
16
3
7
5
3
NA
8
Miao et al. [27]
54
28
26
45.1 ± 13.4
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA not available
Table 2.
The characteristics of included studies and NOS score
Author
Study type
Province
Period of study
In-patients
Asymptomatic
CT negative
Group
Time of symptom onset to CT
NOS score
Zhao et al.
Retrospective
Hunan
NA
Hospitalised
2
8
Nonemergency Group (mild and common types), Emergency Group (severe and fatal types)
Range 0–7 days; median: 1 day
6
Xu et al.
Retrospective
Guangdong
2020/1/23–2020/2/4
Hospitalised
6
0
NA
NA
5
Han et al.
Retrospective
Hubei
2020/1/4–2020/2/3
Hospitalised
0
0
Mild
Range 1–3 days; median: 1 day
4
Yan Li
Retrospective
Hubei
2020/1/23–2020/1/29
Hospitalised
1
0
NA
NA
7
Xiong et al.
Retrospective
Hubei
2020/1/11–2020/2/5
Hospitalised
0
0
NA
Range 1–11 days; mean: 4.5 days
6
Cheng et al.
Retrospective
Shanghai
2020/1/19–2020/2/6
Hospitalised
0
0
NA
NA
7
Xu et al.
Retrospective
Beijing
2020/1–2020/2
Hospitalised
0
9
Mild, Moderate, severe/critically severe
NA
7
Yuan et al.
Retrospective
Hubei
2020/1/1–2020/1/25
Hospitalised
0
0
Survival group, Mortality group
Range 5–11 days; median: 8 days
8
Chung et al.
Retrospective
Guangdong, Jiangxi, Shangdong
2020/1/18–2020/1/27
Hospitalised
2
3
NA
NA
6
Zhang et al.
Retrospective
Sichuan
NA
Hospitalised
0
0
NA
Range 6 h-11 days; median:4.04 days
4
Pan et al.
Retrospective
Hubei
2019/12/30–2020/1/31
Hospitalised
NA
0
NA
NA
5
Shi et al.
Retrospective
Hubei
2019/12/20–2020/1/23
Hospitalised
0
0
NA
Group 1 (subclinical patients; scans done before symptom onset), group 2 (scans done ≤ 1 week after symptom onset), group 3 (> 1–2 weeks), group 4 (> 2–3 weeks)
8
Li et al.
Retrospective
Chongqing
2020/1–2020/2
Hospitalised
0
8
Ordinary group, severe/critical group
NA
6
Bernheim et al.
Retrospective
Jiangxi, Guangdong, Guangxi, Sichuan
2020/1/18–2020/2/2
Hospitalised
0
24
NA
Early phase: ≤ 2 days; intermediate pahse: 3–5 days; late phase:6–12 days
4
Wu et al.
Retrospective
Hubei
2020/1–2020/2
Hospitalised
0
14
NA
7 ± 4 days
4
Guan et al.
Retrospective
Beijing
2020/1/12–2020/2/28
Hospitalised
NA
6
NA
NA
6
Bai et al.
Retrospective
Hunan
2020/1/6–2020/2/20
Hospitalised
NA
37
NA
NA
6
Song et al.
Retrospective
Shanghai
2020/1/20–2020/1/27
Hospitalised
0
3
NA
Interval from disease onset to CT ≤ 4 Days; interval from disease onset to CT > 4 days
7
Miao et al.
Retrospective
Shanghai, Jiangxi
2020/1/12–2020/2/13
Hospitalised
0
28
NA
Less than 14 days
7
NA: not available

The features of chest CT in COVID-19

GGO, consolidation, mixed GGO, and consolidation, air bronchogram sign

The results showed that the combined proportion of GGO was 0.79 (95% CI 0.68, 0.89) (I2 = 95%, P < 0.01) (Fig. 2a), consolidation was 0.34 (95% CI 0.23, 0.47) (I2 = 95%, P < 0.01) (Fig. 2b), mixed GGO and consolidation was 0.46 (95% CI 0.37; 0.56) (I2 = 86%, P < 0.01) (Fig. 2c), air bronchogram sign was 0.41 (95% CI 0.26; 0.55) (I2 = 96%, P < 0.01) (Fig. 2d).

The changes of pulmonary interstitial

The results reported that the combined proportion of crazy paving pattern was 0.32 (95% CI 0.17, 0.47) (I2 = 98%, P < 0.01) (Fig. 3a); interlobular septal thickening was 0.55 (95% CI 0.42, 0.67) (I2 = 84%, P < 0.01) (Fig. 3b); reticulation was 0.30 (95% CI 0.12, 0.48) (I2 = 97%, P < 0.01) (Fig. 3c); bronchial wall thickening was 0.24 (95% CI 0.11, 0.40) (I2 = 94%, P < 0.01) (Fig. 3d); vascular enlargement was 0.74 (95% CI 0.64, 0.86) (I2 = 86%, P < 0.01) (Fig. 3e); subpleural linear opacity was 0.28 (95% CI 0.12, 0.48) (I2 = 92%, P < 0.01) (Fig. 3f).

Rare signs

The results proved that the combined proportion of intrathoracic lymph node enlargement was 0.03 (95% CI 0.00, 0.07) (I2 = 81%, P < 0.01) (Fig. 4a); pleural effusions was 0.03 (95% CI 0.02, 0.06) (I2 = 68%, P < 0.01) (Fig. 4b).

The lesion distribution in lung

The results demonstrated that the combined proportion of central was 0.05 (95% CI 0.01, 0.11) (I2 = 91%, P < 0.01) (Fig. 5a); peripheral was 0.74 (95% CI 0.62, 0.84) (I2 = 94%, P < 0.01) (Fig. 5b); peripheral involving central was 0.38 (95% CI 0.19, 0.75) (I2 = 96%, P < 0.01) (Fig. 5c); diffuse was 0.19 (95% CI 0.06, 0.32) (I2 = 96%, P < 0.01) (Fig. 6a); unifocal involvement was 0.09 (95% CI 0.05, 0.14) (I2 = 58%, P = 0.07) (Fig. 6b); multifocal involvement was 0.57 (95% CI 0.48, 0.68) (I2 = 80%, P < 0.01) (Fig. 6c); unilateral was 0.16 (95% CI 0.10, 0.23) (I2 = 84%, P < 0.01) (Fig. 7a); bilateral was 0.83 (95% CI 0.78, 0.89) (I2 = 89%, P < 0.01) (Fig. 7b); number of lobes involved (> 2) was 0.70 (95% CI 0.61, 0.78) (I2 = 79%, P < 0.01) (Fig. 8a); number of lobes involved (≦ 2) was 0.35 (95% CI 0.26, 0.44) (I2 = 80%, P < 0.01) (Fig. 8b).

Publication bias

A minimum of 10 studies was needed to assess the potential publication bias, therefore we conducted the Egger test on the analyses of GGO, consolidation, mixed GGO and consolidation, crazy paving pattern, air bronchogram sign, pleural effusions, intrathoracic lymph node enlargement, vascular enlargement, peripheral, central, unilateral, bilateral. The results suggested that the publication bias presented in the analyses of mixed GGO and consolidation (P = 0.01078), crazy paving pattern (P = 0.01784), air bronchogram sign (P = 0.01918), bilateral (P = 0.001183) (Table 3).
Table 3
Egger test for publication bias
CT features
P-value
CT features
P value
GGO
0.5425
Intrathoracic lymph node enlargment
0.4386
Consolidation
0.1724
Vascular enlargement
0.1724
Mixed GGO and consolidation
0.01078
Peripheral
0.729
Crazy paving pattern
0.01784
Central
0.3224
Air bronchogram sign
0.01918
Unilateral
0.2431
Pleural effusions
0.9633
Bilateral
0.001183

Discussion

Our study revealed that GGO, vascular enlargement, interlobular septal thickening more frequently occurred in patients with COVID-19. Peripheral, bilateral, involved lobes > 2 might be the features of SARS-CoV-2 in the distribution aspect. In this study, intrathoracic lymph node enlargement, pleural effusions, the lesion distribution in lung of central, unifocal, and unilateral were not frequently observed. Therefore, based on the above features of COVID-19 in chest CT imaging, it might be a promising means for identifying COVID-19.
This novel coronavirus disease is known as COVID-19 by the world health organization [30, 31]. Early detection, early diagnosis, early isolation and early treatment principle are important to control this disease. RT-PCR is the reference standard [6, 7]. But it requires a laboratory-level facility, reliable power supply, expensive equipment and trained personnel to properly conduct RT-PCR tests, which limits its application to some extent [32]. In addition to the nucleic acid test, CT also can be helpful to diagnose COVID-19. The diagnosis of viral pneumonia based on radiologic features by radiologists as one of the diagnostic criteria for COVID-19 according to the diagnosis and treatment program (6th version) published by the National Health Commission of the People’s Republic of China [14, 33]. High-resolution CT is highly sensitive to detect lung abnormalities, which is quite helpful for early diagnosis of the disease that can trigger early treatment and facilitates to contain this emergency disease [19, 34, 35]. Some articles have shown the detailed CT features of COVID-19 [6, 19, 36]. Our study may conclude some common CT imaging features in patients affected by SARS-CoV-2 pneumonia.
The CT patterns of viral pneumonia are related to the pathogenesis of viral infection. Viruses from the same family (e.g. Coronaviridae) have similar pathogenesis [37]. The SARS-CoV-2 belongs to the family Coronaviridae, which includes other viruses like SARS-associated coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) [30]. Some investigations [8, 28, 36] have shown that COVID-19 pneumonia CT findings were partially similar to other viral pneumonia, like SARS, MERS and H7N9 pneumonia [3840]. The pathological changes included thickening of the basement membrane of the alveoli capillary, edema of the alveoli septum, pulmonary hyaline membrane formation, inflammatory cell infiltration and inflammatory edema, pulmonary interstitial hyperplasia and fibrosis, apoptosis of alveolar epithelium cells [41, 42]. Based on the image characteristic of SARS-CoV-2 pneumonia which had been reported in some articles [4143], the pathology of GGOs may be the thickening of alveolar wall, collapse of alveolar cavity, reduction of air content in alveolar cavity and inflammatory cells infiltration or a combination of these features. We estimated the pathological mechanism of COVID-19 includes bronchoalveolar destruction and damage to lung parenchyma near the bronchioles in the early stages [43]. In the late stage, diffuse alveolar injury and acute fibrous and organic pneumonia can be observed [44]. This pathological pattern is the same as imaging pattern like GGO at first and then consolidation dense consolidative lesions, early in the disease. With the progression of the disease, lesions often turn more linear fashion with a predilection for the lung periphery (and somewhat with a “crazy” paving pattern or emergence of a “reverse halo” sign).
We also observed some interstitial changes in patients with COVID-19. Hitherto, some autopsy cases have revealed the pathological features of COVID-19 [43, 4547]. The pathological changes of pulmonary fibrosis injury in COVID-19 include extensive diffuse alveolar injury with bilateral edema, protein or fibrin exudation, and diffuse reactive proliferation of type II pneumocytes. It was even can be observed that interstitial fibroblast proliferation caused alveolar septa to thicken, forming hyaline membranes consistent with fibrosis. These pathological changes may be due to a disruption of the ACE/ACE2 (angiotensin-converting enzyme/ angiotensin-converting enzyme 2) balance [4853], which were presented as the crazy paving-pattern, interlobular septal thickening, bronchial wall thickening on chest CT.
Lymphadenopathy and pleural effusions are atypical imaging features in COVID-19 patients. Severe/critical patients showed more lymph node enlargement, and pleural effusion [8, 22]. Li et al. [29] reported that lymphadenopathy and pleural effusions were poor prognostic indicators according to his logistic regression models in COVID-19 pneumonia. Lymphadenopathy may be related to the immune response. The immune response of patients with COVID-19 pneumonia is stronger than that of other viral pneumonia, especially those with moderate to severe COVID-19 pneumonia [29]. Similarly, lymphadenopathy and pleural effusions are important predictors of an unfavorable outcome in patients infected with MERS­CoV or avian influenza H5N1 [5456]. However, articles on the above two imaging changes are less, and more evidence is needed to verify these conclusions.
Pulmonary lesions were most commonly in the peripheral, which was related to ACE2 [57]. ACE2 has been established as a functional receptor for SARS-CoV, which plays a crucial role in the pathogenesis of COVID-19 [58]. ACE2 was abundantly expressed on the surface of alveolar type II pneumocytes and the capillary endothelial cells [57, 59], where are the targets of viral entry and replication. As the virus invades, type II pneumocytes and capillary endothelial cells are constantly destroyed, which may explain why most lesions are located peripherally.
According to the results of most articles, lesions are mostly distributed peripherally in the lung, which facilitates detection by lung ultrasonography (US) [8, 60]. Xing et al. found abnormal US results in patients with COVID-19 pneumonia: mainly B-lines [61]. In that study, US examinations was performed at different stages of disease, B-lines showed parallel changes with the clinical severity. However, the unspecific abnormalities realizations in chest CT increase with age, and similarly, the number of chest areas positive for B-lines increases in the elderly [62]. Age-related confounding factors should be taken into consideration in clinical practice in order to avoid misdiagnoses.
Most of the literature has focused on CT manifestations of COVID-19, however, due to limited CT availability in regions of the world, infection control issues related to access to CT rooms, the inefficiencies in decontamination, and the reduction in radiological service availability due to the widespread use of CT for the diagnosis and follow up of COVID-19, there is the need for alternative diagnostic tools. The US could be proposed for the diagnosis or follow up to minimize the risk of cross-infection. Additionally, the US may also play a vital role in areas around the world with limited access to other diagnostic tools, even in austere environments [62].
Nevertheless, we also encountered some limitations: (1) eligible studies were retrospective studies; (2) large heterogeneity among included articles might affect the reliability and stability of results we analyzed to some extent.

Conclusions

GGO, vascular enlargement, interlobular septal thickening more frequently occurred in patients with COVID-19. Peripheral, bilateral, involved lobes > 2 might be the features of COVID-19 in the distribution aspect. Based on the above features of COVID-19 in chest CT imaging, it might be a promising means for identifying COVID-19.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12985-020-01432-9.

Acknowledgements

Not applicable.
Not applicable.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457–60.PubMedPubMedCentral Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457–60.PubMedPubMedCentral
3.
Zurück zum Zitat Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2019;2020:200642. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2019;2020:200642.
4.
Zurück zum Zitat Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81.PubMedPubMedCentral Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81.PubMedPubMedCentral
5.
Zurück zum Zitat Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.PubMedPubMedCentral Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.PubMedPubMedCentral
6.
Zurück zum Zitat Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.PubMedPubMedCentral Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.PubMedPubMedCentral
7.
Zurück zum Zitat Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3.PubMedPubMedCentralCrossRef Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–34.PubMedPubMedCentral Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–34.PubMedPubMedCentral
9.
Zurück zum Zitat Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;2020:200432. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;2020:200432.
10.
Zurück zum Zitat Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for TYPICAL 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 2020;2020:200343. Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for TYPICAL 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 2020;2020:200343.
11.
Zurück zum Zitat Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol. 2020;214(5):1072–7.PubMedCrossRef Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol. 2020;214(5):1072–7.PubMedCrossRef
12.
Zurück zum Zitat Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020;47(5):1275–80.PubMedCrossRef Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020;47(5):1275–80.PubMedCrossRef
13.
Zurück zum Zitat Han R, Huang L, Jiang H, Dong J, Peng H, Zhang D. Early clinical and CT manifestations of coronavirus disease 2019 (COVID-19) pneumonia. AJR Am J Roentgenol. 2020;215:1–6.CrossRef Han R, Huang L, Jiang H, Dong J, Peng H, Zhang D. Early clinical and CT manifestations of coronavirus disease 2019 (COVID-19) pneumonia. AJR Am J Roentgenol. 2020;215:1–6.CrossRef
14.
Zurück zum Zitat Li Y, Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management. AJR Am J Roentgenol. 2020;214(6):1280–6.PubMedCrossRef Li Y, Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management. AJR Am J Roentgenol. 2020;214(6):1280–6.PubMedCrossRef
15.
Zurück zum Zitat Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, et al. Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes. Invest Radiol. 2020;55(6):332–9.PubMedCrossRef Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, et al. Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes. Invest Radiol. 2020;55(6):332–9.PubMedCrossRef
16.
Zurück zum Zitat Cheng Z, Lu Y, Cao Q, Qin L, Pan Z, Yan F, et al. Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China. AJR Am J Roentgenol. 2019;2020:1–6. Cheng Z, Lu Y, Cao Q, Qin L, Pan Z, Yan F, et al. Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China. AJR Am J Roentgenol. 2019;2020:1–6.
17.
Zurück zum Zitat Xu YH, Dong JH, An WM, Lv XY, Yin XP, Zhang JZ, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect. 2020;80(4):394–400.PubMedPubMedCentralCrossRef Xu YH, Dong JH, An WM, Lv XY, Yin XP, Zhang JZ, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect. 2020;80(4):394–400.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS ONE. 2020;15(3):e230548.CrossRef Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS ONE. 2020;15(3):e230548.CrossRef
19.
Zurück zum Zitat Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020;295(1):202–7.PubMedCrossRef Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020;295(1):202–7.PubMedCrossRef
20.
Zurück zum Zitat Zhang S, Li H, Huang S, You W, Sun H. High-resolution CT features of 17 cases of corona virus disease 2019 in Sichuan Province, China. Eur Respir J. 2020;55(4):2000334.PubMedPubMedCentralCrossRef Zhang S, Li H, Huang S, You W, Sun H. High-resolution CT features of 17 cases of corona virus disease 2019 in Sichuan Province, China. Eur Respir J. 2020;55(4):2000334.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Pan Y, Guan H, Zhou S, Wang Y, Li Q, Zhu T, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan. China Eur Radiol. 2020;2020:1. Pan Y, Guan H, Zhou S, Wang Y, Li Q, Zhu T, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan. China Eur Radiol. 2020;2020:1.
22.
Zurück zum Zitat Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest Radiol. 2020;55(6):327–31.PubMedCrossRef Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest Radiol. 2020;55(6):327–31.PubMedCrossRef
23.
Zurück zum Zitat Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020;295(3):200463.PubMedCrossRef Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA, Zhang N, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020;295(3):200463.PubMedCrossRef
24.
Zurück zum Zitat Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L, et al. Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features. Invest Radiol. 2020;55(5):257–61.PubMedPubMedCentralCrossRef Wu J, Wu X, Zeng W, Guo D, Fang Z, Chen L, et al. Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features. Invest Radiol. 2020;55(5):257–61.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Guan CS, Lv ZB, Yan S, Du YN, Chen H, Wei LG, et al. Imaging features of coronavirus disease 2019 (COVID-19): evaluation on thin-section CT. Acad Radiol. 2020;27(5):609–13.PubMedPubMedCentralCrossRef Guan CS, Lv ZB, Yan S, Du YN, Chen H, Wei LG, et al. Imaging features of coronavirus disease 2019 (COVID-19): evaluation on thin-section CT. Acad Radiol. 2020;27(5):609–13.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020;2020:200823. Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020;2020:200823.
27.
Zurück zum Zitat Miao C, Jin M, Miao L, Yang X, Huang P, Xiong H, et al. Early chest computed tomography to diagnose COVID-19 from suspected patients: a multicenter retrospective study. Am J Emerg Med. 2020;S0735-6757(20):30281–3. Miao C, Jin M, Miao L, Yang X, Huang P, Xiong H, et al. Early chest computed tomography to diagnose COVID-19 from suspected patients: a multicenter retrospective study. Am J Emerg Med. 2020;S0735-6757(20):30281–3.
28.
Zurück zum Zitat Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020;295(1):210–7.PubMedCrossRef Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020;295(1):210–7.PubMedCrossRef
29.
Zurück zum Zitat Das KM, Lee EY, Enani MA, AlJawder SE, Singh R, Bashir S, et al. CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus. AJR Am J Roentgenol. 2015;204(4):736–42.PubMedCrossRef Das KM, Lee EY, Enani MA, AlJawder SE, Singh R, Bashir S, et al. CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus. AJR Am J Roentgenol. 2015;204(4):736–42.PubMedCrossRef
30.
Zurück zum Zitat Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.PubMedPubMedCentral Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.PubMedPubMedCentral
32.
Zurück zum Zitat Nayak S, Blumenfeld NR, Laksanasopin T, Sia SK. Point-of-care diagnostics: recent developments in a connected age. Anal Chem. 2017;89(1):102–23.PubMed Nayak S, Blumenfeld NR, Laksanasopin T, Sia SK. Point-of-care diagnostics: recent developments in a connected age. Anal Chem. 2017;89(1):102–23.PubMed
33.
Zurück zum Zitat National Health Commission of the People’s Republic of China website. Diagnosis and treatment of novel coronavirus infection (trial version 6). 2020;37(3):242–6. National Health Commission of the People’s Republic of China website. Diagnosis and treatment of novel coronavirus infection (trial version 6). 2020;37(3):242–6.
34.
Zurück zum Zitat Paul NS, Roberts H, Butany J, Chung T, Gold W, Mehta S, et al. Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience. Radiographics. 2004;24(2):553–63.PubMed Paul NS, Roberts H, Butany J, Chung T, Gold W, Mehta S, et al. Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience. Radiographics. 2004;24(2):553–63.PubMed
35.
Zurück zum Zitat Lei J, Li J, Li X, Qi X. CT Imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020;295(1):18.PubMed Lei J, Li J, Li X, Qi X. CT Imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020;295(1):18.PubMed
36.
Zurück zum Zitat Koo HJ, Lim S, Choe J,Choi SH, Sung H, Do KH. Radiographic and CT features of viral pneumonia1. Radiographics. 2018;38(3):719–39.PubMed Koo HJ, Lim S, Choe J,Choi SH, Sung H, Do KH. Radiographic and CT features of viral pneumonia1. Radiographics. 2018;38(3):719–39.PubMed
37.
Zurück zum Zitat Wang Q, Zhang Z, Shi Y, Jiang Y. Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: radiologic findings. Radiology. 2013;268(3):882–9.PubMed Wang Q, Zhang Z, Shi Y, Jiang Y. Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: radiologic findings. Radiology. 2013;268(3):882–9.PubMed
38.
Zurück zum Zitat Wong KT, Antonio GE, Hui DS, Lee N, Yuen EH, Wu A, et al. Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease1. Radiology. 2003;228(2):395–400.PubMed Wong KT, Antonio GE, Hui DS, Lee N, Yuen EH, Wu A, et al. Thin-section CT of severe acute respiratory syndrome: evaluation of 73 patients exposed to or with the disease1. Radiology. 2003;228(2):395–400.PubMed
39.
Zurück zum Zitat Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A, Madani TA. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol. 2014;203(4):782–7.PubMed Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A, Madani TA. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol. 2014;203(4):782–7.PubMed
40.
Zurück zum Zitat Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361(9371):1773–8.PubMedPubMedCentralCrossRef Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361(9371):1773–8.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Lang ZW, Zhang LJ, Zhang SJ, Meng X, Li JQ, Song CZ, et al. A clinicopathological study on 3 cases of severe acute respiratory syndrome. Zhonghua Bing Li Xue Za Zhi. 2003;32(3):201–4.PubMed Lang ZW, Zhang LJ, Zhang SJ, Meng X, Li JQ, Song CZ, et al. A clinicopathological study on 3 cases of severe acute respiratory syndrome. Zhonghua Bing Li Xue Za Zhi. 2003;32(3):201–4.PubMed
42.
Zurück zum Zitat Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.PubMedPubMedCentralCrossRef Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol. 2003;200(3):282–9.PubMedPubMedCentralCrossRef Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol. 2003;200(3):282–9.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol. 2020;153(6):725–33. Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol. 2020;153(6):725–33.
45.
Zurück zum Zitat Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020;33(6):1007–14.PubMedCrossRefPubMedCentral Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020;33(6):1007–14.PubMedCrossRefPubMedCentral
46.
Zurück zum Zitat Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15(5):700–4.PubMedPubMedCentralCrossRef Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15(5):700–4.PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012;2012:256294.PubMedPubMedCentralCrossRef Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012;2012:256294.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, et al. The emerging role of ACE2 in physiology and disease. J Pathol. 2007;212(1):1–11.PubMedPubMedCentralCrossRef Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, et al. The emerging role of ACE2 in physiology and disease. J Pathol. 2007;212(1):1–11.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875–9.PubMedPubMedCentralCrossRef Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875–9.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112–6.PubMedPubMedCentralCrossRef Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112–6.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Li Y, Zeng Z, Cao Y, Liu Y, Ping F, Liang M, et al. Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-kappaB signaling pathways. Sci Rep. 2016;6:27911.PubMedPubMedCentralCrossRef Li Y, Zeng Z, Cao Y, Liu Y, Ping F, Liang M, et al. Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-kappaB signaling pathways. Sci Rep. 2016;6:27911.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Gaur P, Saini S, Vats P, Kumar B. Regulation, signalling and functions of hormonal peptides in pulmonary vascular remodelling during hypoxia. Endocrine. 2018;59(3):466–80.PubMedCrossRef Gaur P, Saini S, Vats P, Kumar B. Regulation, signalling and functions of hormonal peptides in pulmonary vascular remodelling during hypoxia. Endocrine. 2018;59(3):466–80.PubMedCrossRef
53.
Zurück zum Zitat Li X, Fang X, Bian Y, Lu J. Comparison of chest CT findings between COVID-19 pneumonia and other types of viral pneumonia: a two-center retrospective study. Eur Radiol. 2020;2020:1–9. Li X, Fang X, Bian Y, Lu J. Comparison of chest CT findings between COVID-19 pneumonia and other types of viral pneumonia: a two-center retrospective study. Eur Radiol. 2020;2020:1–9.
54.
Zurück zum Zitat Das KM, Lee EY, Al Jawder SE, Enani MA, Singh R, Skakni L, et al. Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients. AJR Am J Roentgenol. 2015;205(3):W267–74.PubMedCrossRef Das KM, Lee EY, Al Jawder SE, Enani MA, Singh R, Skakni L, et al. Acute Middle East respiratory syndrome coronavirus: temporal lung changes observed on the chest radiographs of 55 patients. AJR Am J Roentgenol. 2015;205(3):W267–74.PubMedCrossRef
55.
Zurück zum Zitat Qureshi NR, Hien TT, Farrar J, Gleeson FV. The radiologic manifestations of H5N1 avian influenza. J Thorac Imaging. 2006;21(4):259–64.PubMedCrossRef Qureshi NR, Hien TT, Farrar J, Gleeson FV. The radiologic manifestations of H5N1 avian influenza. J Thorac Imaging. 2006;21(4):259–64.PubMedCrossRef
57.
Zurück zum Zitat Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–7. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–7.
58.
Zurück zum Zitat Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23):14614–21.PubMedPubMedCentralCrossRef Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23):14614–21.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol. 2020;215(1):127–32.PubMedCrossRef Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol. 2020;215(1):127–32.PubMedCrossRef
61.
Zurück zum Zitat Ciccarese F, Chiesa AM, Feletti F, Vizioli L, Pasquali M, Forti P, et al. The senile lung as a possible source of pitfalls on chest ultrasonography and computed tomography. Respiration. 2015;90(1):56–62.PubMedCrossRef Ciccarese F, Chiesa AM, Feletti F, Vizioli L, Pasquali M, Forti P, et al. The senile lung as a possible source of pitfalls on chest ultrasonography and computed tomography. Respiration. 2015;90(1):56–62.PubMedCrossRef
62.
Zurück zum Zitat Feletti F, Mucci V, Aliverti A. Chest ultrasonography in modern day extreme settings: from military setting and natural disasters to space flights and extreme sports. Can Respir J. 2018;2018:8739704.PubMedPubMedCentralCrossRef Feletti F, Mucci V, Aliverti A. Chest ultrasonography in modern day extreme settings: from military setting and natural disasters to space flights and extreme sports. Can Respir J. 2018;2018:8739704.PubMedPubMedCentralCrossRef
Metadaten
Titel
The chest CT features of coronavirus disease 2019 (COVID-19) in China: a meta-analysis of 19 retrospective studies
verfasst von
Haitao Yang
Yuzhu Lan
Xiujuan Yao
Sheng Lin
Baosong Xie
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Virology Journal / Ausgabe 1/2020
Elektronische ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-020-01432-9

Weitere Artikel der Ausgabe 1/2020

Virology Journal 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.